May 05, 2026
The Food and Drug Administration has named Katherine Szarama, PhD, acting director of the Center for Biologics Evaluation and Research (CBER), Politico reported.
Szarama joined CBER in December 2025 as deputy director. She previously held roles at the Advanced Research Projects Agency for Health (ARPA-H), Arnold Ventures, Emerson Collective, and the Centers for Medicare and Medicaid Services.
She succeeds Vinay Prasad, MD, MPH, who departed the agency at the end of April.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
